Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Male hormones worsen kidney transplant damage, but blocking them helps.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.